THE PHARMACOLOGY OF REVERSIBLE MONOAMINE-OXIDASE INHIBITORS

被引：37

作者：

AMREIN, R ^{[1
]}

ALLEN, SR ^{[1
]}

GUENTERT, TW ^{[1
]}

HARTMANN, D ^{[1
]}

LORSCHEID, T ^{[1
]}

SCHOERLIN, MP ^{[1
]}

VRANESIC, D ^{[1
]}

机构：

[1] F HOFFMANN LA ROCHE & CO LTD,DEPT PKF TN,CH-4002 BASEL,SWITZERLAND

来源：

BRITISH JOURNAL OF PSYCHIATRY | 1989年 / 155卷

关键词：

D O I：

10.1192/S0007125000297511

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：66 / 71

页数：6

共 35 条

[11]

DAVIS WILLIAM A., 1958, JOUR CLIN AND EXPTL PSYCHOPATH, V19, P1

[12] POTENTIATION OF THE BEHAVIORAL-EFFECTS OF THE ANTI-DEPRESSANT PHENELZINE BY DEUTERIUM SUBSTITUTION [J].

DOURISH, CT ;

DEWAR, KM ;

DYCK, LE ;

BOULTON, AA .

PSYCHOPHARMACOLOGY, 1983, 81 (02) :122-125

[13]

FELNER AE, 1979, BIOCHEM PHARMACOL, V28, P995, DOI 10.1016/0006-2952(79)90293-4

[14]

HELMKAMP GM, 1968, J BIOL CHEM, V243, P3229

[15] INHIBITION OF MONOAMINE-OXIDASE BY MOCLOBEMIDE - EFFECTS ON MONOAMINE METABOLISM AND SECRETION OF ANTERIOR-PITUITARY HORMONES AND CORTISOL IN HEALTHY-VOLUNTEERS [J].

KOULU, M ;

SCHEININ, M ;

KAARTTINEN, A ;

KALLIO, J ;

PYYKKO, K ;

VUORINEN, J ;

ZIMMER, RH .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (02) :243-255

[16]

KUMMER J, 1989, IN PRESS EFFICACY SA

[17] ATYPICAL FACIAL PAIN AND DEPRESSION [J].

LASCELLE.RG .

BRITISH JOURNAL OF PSYCHIATRY, 1966, 112 (488) :651-&

[18] PHARMACOKINETICS OF TRANYLCYPROMINE IN PATIENTS WHO ARE DEPRESSED - RELATIONSHIP TO CARDIOVASCULAR EFFECTS [J].

MALLINGER, AG ;

EDWARDS, DJ ;

HIMMELHOCH, JM ;

KNOPF, S ;

EHLER, J .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (04) :444-450

[19]

MARTIN JR, 1989, ALZHEIMERS DISEASE A

[20] SUBSTRATE-SELECTIVE MONO-AMINE OXIDASES - INHIBITOR, TISSUE, SPECIES AND FUNCTIONAL DIFFERENCES [J].

MURPHY, DL .

BIOCHEMICAL PHARMACOLOGY, 1978, 27 (15) :1889-1893

← 1 2 3 4 →